Ceramide alters endothelial cell permeability by a nonapoptotic mechanism.
Ceramide is a lipid second messenger that was recently identified as mediator of pulmonary edema in vivo. Here, we investigated the effect of ceramide on the permeability of confluent endothelial cell monolayers. In monolayers of bovine pulmonary artery and human microvascular pulmonary endothelial cells, incubation with C6-ceramide for 3 h elevated permeability in a concentration-dependent manner, whereas dihydroceramide was without effect. After 3 h of incubation with ceramide, we found no signs of necrosis (release of lactate dehydrogenase, loss of thiazylyl blue reduction) or apoptosis (ssDNA, caspase-8 activity). The increased endothelial permeability in response to ceramide was attenuated by the Ser/Thr protein kinase inhibitors K252a, K252b and H-7, as well as by the phosphatidylinositol-specific phospholipase C inhibitor L108. Since in some systems sphingosine-1-phosphate (S1P) acts antagonistic to ceramide, the effect of S1P was studied. S1P transiently increased endothelial cell resistance, whether it was given together with ceramide or 90 min thereafter. These data provide a novel example of the antagonism between S1P and ceramide. Our findings further suggest that ceramide alters vascular permeability by activation of pathways dependent on unidentified phospholipase C and Ser/Thr kinase isoenzymes.
Lindner
Karsten
K
Division Pulmonary Pharmacology, Research Center Borstel, Parkallee 22, Borstel D-23845, Germany.
Uhlig
Ulrike
U
Uhlig
Stefan
S
D000818:Animals; D017209:Apoptosis / Q000502:physiology*; D002417:Cattle; D002463:Cell Membrane Permeability / Q000502:physiology*; D002478:Cells, Cultured; D002518:Ceramides / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D042783:Endothelial Cells / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure; D004730:Endothelium, Vascular / Q000166:cytology / Q000502:physiology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D008246:Lysophospholipids / Q000502:physiology; D009336:Necrosis; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000502:physiology
D002518:Ceramides; D004791:Enzyme Inhibitors; D008246:Lysophospholipids; C101954:N-caproylsphingosine; C060506:sphingosine 1-phosphate; D013110:Sphingosine
J Biol Chem. 2003 Nov 21;278(47):47281-90
12954648
J Nutr. 2003 Nov;133(11):3343-9
14608042
Blood. 1983 Sep;62(3):549-56
6309278
Nature. 1983 Nov 3-9;306(5938):67-9
6605482
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
6606682
Biochemistry. 1984 Oct 9;23(21):5036-41
6238627
J Cell Physiol. 1986 Jul;128(1):96-104
3722274
Biochem Biophys Res Commun. 1987 Jan 30;142(2):436-40
3028414
Biochem Biophys Res Commun. 1987 Apr 14;144(1):35-40
3579911
J Biol Chem. 1987 Jun 5;262(16):7796-801
3108259
Am J Physiol. 1989 Sep;257(3 Pt 1):C562-7
2782396
Biochem Biophys Res Commun. 1991 Nov 27;181(1):423-9
1659814
Cancer Res. 1992 May 15;52(10):2835-40
1316230
J Biotechnol. 1992 Sep;25(3):231-43
1368802
Arterioscler Thromb Vasc Biol. 1996 Mar;16(3):488-96
8630677
Circ Res. 1996 Oct;79(4):736-47
8831497
J Exp Med. 1997 Dec 1;186(11):1831-41
9382882
J Biol Chem. 1998 Oct 16;273(42):27389-95
9765267
Cell Struct Funct. 1998 Oct;23(5):255-64
9872566
Am J Physiol. 1999 Mar;276(3 Pt 1):L481-90
10070113
J Biol Chem. 1999 May 7;274(19):13643-9
10224136
Blood. 1999 Jun 15;93(12):4293-9
10361127
Endocrinology. 2005 Mar;146(3):1312-20
15591142
Biochim Biophys Acta. 2000 May 31;1485(2-3):63-99
10832090
Am J Physiol Lung Cell Mol Physiol. 2001 Jun;280(6):L1168-78
11350795
J Immunol Methods. 2001 Jul 1;253(1-2):133-44
11384675
J Clin Invest. 2001 Sep;108(5):689-701
11544274
Am J Physiol Lung Cell Mol Physiol. 2001 Oct;281(4):L958-68
11557600
J Appl Physiol (1985). 2001 Oct;91(4):1487-500
11568129
J Cell Sci. 2002 Jun 15;115(Pt 12):2475-84
12045218
J Clin Invest. 2002 Jul;110(1):3-8
12093880
J Biol Chem. 2002 Aug 23;277(34):30469-76
12063265
Biochem Biophys Res Commun. 2003 Feb 7;301(2):564-71
12565900
Biochem J. 2003 Apr 1;371(Pt 1):199-204
12534346
Am J Physiol Lung Cell Mol Physiol. 2003 Jul;285(1):L258-67
12626332
Oncogene. 2003 Sep 1;22(37):5897-906
12947396
Nat Med. 2004 Feb;10(2):155-60
14704790